Danville, Pa.-based Geisinger will hand over the private patient information for 1 million patients to the defense team for a ...

A researcher from Rochester, Minn.-based Mayo Clinic sent research data containing protected health information to his ...

For patient advocates and health economists, cases like Ekirch’s illustrate why prior authorization has become such a chronic ...

States are suing the National Institutes of Health over ending life-saving medical research grants that Trump officials say ...

WILLIAMSPORT — The defense for the California man charged in the 2023 Geisinger Health System data breach will receive ...

On Wednesday, two pharmacy benefit managers filed a motion to recuse U.S. District Judge Dan Polster after he failed to order ...

A committee of experts that advises HHS on emerging ethical and legal issues in human health research has been disbanded, ...

Recent changes in federal immigration enforcement practices have prompted renewed attention to how healthcare providers manage requests from ...

Senate Bill 164 would provide transparency for patients on the use of AI by health insurers by making sure there is human oversight on whether or not someone receives health coverage.

BioArctic AB's (publ) partner Eisai today announced that the European Commission (EC) has decided to refer the marketing authorisation approval decision of lecanemab in the EU to the Appeal Committee.

To understand how prior authorization works with your plan, contact your insurer for its specific rules. The information on this website may assist you in making personal decisions about insurance ...

There have been hundreds of measles cases reported in the U.S. since the beginning of the year. Here's what you need to know about measles immunity.